These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 28592751)

  • 1. Effect of Ezetimibe on Stabilization and Regression of Intracoronary Plaque - The ZIPANGU Study.
    Ueda Y; Hiro T; Hirayama A; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
    Circ J; 2017 Oct; 81(11):1611-1619. PubMed ID: 28592751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study.
    Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
    J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of ezetimibe addition on coronary atheroma regression in patients with prior statin therapy: Subanalysis of PRECISE-IVUS trial.
    Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    Eur J Prev Cardiol; 2016 Sep; 23(14):1524-8. PubMed ID: 27296705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combined ezetimibe and statin therapy versus statin therapy alone on coronary plaque volume assessed by intravascular ultrasound: A systematic review and meta-analysis.
    Mirzaee S; Thein PM; Nogic J; Nerlekar N; Nasis A; Brown AJ
    J Clin Lipidol; 2018; 12(5):1133-1140.e15. PubMed ID: 30318063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Ezetimibe-Statin Combination Therapy on Coronary Atherosclerosis in Acute Coronary Syndrome.
    Hibi K; Sonoda S; Kawasaki M; Otsuji Y; Murohara T; Ishii H; Sato K; Koshida R; Ozaki Y; Sata M; Morino Y; Miyamoto T; Amano T; Morita S; Kozuma K; Kimura K; Fujiwara H;
    Circ J; 2018 Feb; 82(3):757-766. PubMed ID: 29212965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound--the TOGETHAR trial.
    Kodama K; Komatsu S; Ueda Y; Takayama T; Yajima J; Nanto S; Matsuoka H; Saito S; Hirayama A
    Circ J; 2010 Sep; 74(9):1922-8. PubMed ID: 20625215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of statin-ezetimibe combination on coronary atheroma plaque in patients with and without chronic kidney disease - Sub-analysis of PRECISE-IVUS trial.
    Fujisue K; Nagamatsu S; Shimomura H; Yamashita T; Nakao K; Nakamura S; Ishihara M; Matsui K; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Sakamoto K; Izumiya Y; Kaikita K; Hokimoto S; Ogawa H; Tsujita K
    Int J Cardiol; 2018 Oct; 268():23-26. PubMed ID: 29925472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: Subanalysis of PRECISE-IVUS trial.
    Tsujita K; Yamanaga K; Komura N; Sakamoto K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    Atherosclerosis; 2016 Aug; 251():367-372. PubMed ID: 27318866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial.
    Nakano Y; Yamamoto M; Matoba T; Katsuki S; Nakashiro S; Takase S; Akiyama Y; Nagata T; Mukai Y; Inoue S; Oi K; Higo T; Takemoto M; Suematsu N; Eshima K; Miyata K; Usui M; Sadamatsu K; Kadokami T; Hironaga K; Ichi I; Todaka K; Kishimoto J; Tsutsui H
    J Atheroscler Thromb; 2023 Aug; 30(8):907-918. PubMed ID: 36450458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Atorvastatin (10 mg) and Ezetimibe (10 mg) Combination Compared to Atorvastatin (40 mg) Alone on Coronary Atherosclerosis.
    Oh PC; Jang AY; Ha K; Kim M; Moon J; Suh SY; Lee K; Han SH; Kang WC
    Am J Cardiol; 2021 Sep; 154():22-28. PubMed ID: 34238445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
    Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
    J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combination therapy of ezetimibe and rosuvastatin on regression of coronary atherosclerosis in patients with coronary artery disease.
    Masuda J; Tanigawa T; Yamada T; Nishimura Y; Sasou T; Nakata T; Sawai T; Fujimoto N; Dohi K; Miyahara M; Nishikawa M; Nakamura M; Ito M
    Int Heart J; 2015 May; 56(3):278-85. PubMed ID: 25902885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
    Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
    Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
    Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
    J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMBINATION THERAPY EFFECTIVENESS OF EZETIMIBE AND ATORVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROME.
    Japaridze L; Sadunishvili M; Megreladze I
    Georgian Med News; 2016 Mar; (252):15-22. PubMed ID: 27119829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease.
    Okada K; Iwahashi N; Endo T; Himeno H; Fukui K; Kobayashi S; Shimizu M; Iwasawa Y; Morita Y; Wada A; Shigemasa T; Mochida Y; Shimizu T; Sawada R; Uchino K; Umemura S; Kimura K
    Atherosclerosis; 2012 Oct; 224(2):454-6. PubMed ID: 22892323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.